JPH10512267A5 - - Google Patents
Info
- Publication number
- JPH10512267A5 JPH10512267A5 JP1996521917A JP52191796A JPH10512267A5 JP H10512267 A5 JPH10512267 A5 JP H10512267A5 JP 1996521917 A JP1996521917 A JP 1996521917A JP 52191796 A JP52191796 A JP 52191796A JP H10512267 A5 JPH10512267 A5 JP H10512267A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU0590 | 1995-01-16 | ||
| AUPN0590A AUPN059095A0 (en) | 1995-01-16 | 1995-01-16 | Novel lipopeptide |
| AU0589 | 1995-01-16 | ||
| AUPN0589A AUPN058995A0 (en) | 1995-01-16 | 1995-01-16 | Novel peptide |
| PCT/AU1996/000018 WO1996022306A1 (en) | 1995-01-16 | 1996-01-16 | Novel peptide |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005034053A Division JP2005145985A (ja) | 1995-01-16 | 2005-02-10 | 新規ペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPH10512267A JPH10512267A (ja) | 1998-11-24 |
| JPH10512267A5 true JPH10512267A5 (OSRAM) | 2004-11-11 |
| JP3665342B2 JP3665342B2 (ja) | 2005-06-29 |
Family
ID=25644844
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP52191796A Expired - Fee Related JP3665342B2 (ja) | 1995-01-16 | 1996-01-16 | 新規ペプチド |
| JP2005034053A Pending JP2005145985A (ja) | 1995-01-16 | 2005-02-10 | 新規ペプチド |
| JP2006002633A Expired - Fee Related JP4522367B2 (ja) | 1995-01-16 | 2006-01-10 | 新規ペプチド |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005034053A Pending JP2005145985A (ja) | 1995-01-16 | 2005-02-10 | 新規ペプチド |
| JP2006002633A Expired - Fee Related JP4522367B2 (ja) | 1995-01-16 | 2006-01-10 | 新規ペプチド |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6057294A (OSRAM) |
| EP (1) | EP0804469B1 (OSRAM) |
| JP (3) | JP3665342B2 (OSRAM) |
| AU (1) | AU694602B2 (OSRAM) |
| CA (1) | CA2210812C (OSRAM) |
| DE (1) | DE69617396T2 (OSRAM) |
| ES (1) | ES2168456T3 (OSRAM) |
| WO (1) | WO1996022306A1 (OSRAM) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69617396T2 (de) * | 1995-01-16 | 2002-09-05 | Northern Sydney Area Health Service, St. Leonards | T-Zellen beeinflussende Peptide |
| WO1997035881A2 (en) * | 1996-03-27 | 1997-10-02 | Ng Gordon Y K | Receptor and transporter antagonists |
| CA2257973C (en) | 1996-06-11 | 2010-02-02 | Northern Sydney Area Health Services | T cell antigen receptor peptides |
| US20050070478A1 (en) * | 1996-06-11 | 2005-03-31 | Northern Sydney Area Health Services | T cell antigen receptor peptides |
| BR9808529B1 (pt) | 1997-04-11 | 2010-10-05 | oligopeptìdeo. | |
| US6696545B1 (en) | 1997-04-11 | 2004-02-24 | Sangstat Medical Corporation | Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| JP2003534287A (ja) * | 2000-05-19 | 2003-11-18 | ユニバーシティ・オブ・メリーランド， ボルティモア | 糖尿病発症を予防または遅延させるためのゾヌリンのペプチドアンタゴニストの使用方法 |
| US7094413B2 (en) | 2002-01-24 | 2006-08-22 | Sangstat Medical Corporation | Combined therapy for treatment of HIV infection |
| CA2565886A1 (en) * | 2004-05-27 | 2005-12-08 | Gropep Limited | Treatment of inflammatory airway disease |
| WO2007034490A2 (en) * | 2005-09-22 | 2007-03-29 | Yeda Research And Development Co. Ltd., At The Weizmann Institute Of Science | Diastereomeric peptides for modulating t cell immunity |
| EP1870420A1 (en) * | 2006-06-23 | 2007-12-26 | Max-Delbrück-Centrum Für Molekulare Medizin | Peptides regulating the surface expression of the T cell receptor |
| US20120077732A1 (en) * | 2008-11-24 | 2012-03-29 | Sydney West Area Health Service | Cyclic peptides and uses thereof |
| US10138276B2 (en) | 2009-09-30 | 2018-11-27 | Signablok, Inc. | Inhibition of TCR signaling with peptide variants |
| WO2011047097A2 (en) | 2009-10-13 | 2011-04-21 | Sigalov Alexander B | Inhibition of trem receptor signaling with peptide variants |
| AU2018243571B2 (en) | 2017-03-31 | 2024-03-07 | The Board Of Trustees Of The Leland Standford Junior University | Methods of treating T cell exhaustion by inhibiting or modulating T cell receptor signaling |
| CA3109702A1 (en) | 2018-08-13 | 2020-02-20 | Signablok, Inc. | Peptides and compositions for targeted treatment and imaging |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5888512A (en) * | 1987-01-30 | 1999-03-30 | Board Of Trustees Of The Leland Stanford Junior University | Lymphocyte activity regulation by HLA peptides |
| JPH04503073A (ja) * | 1989-01-31 | 1992-06-04 | アボツト・ラボラトリーズ | アナフィラトキシン受容体リガンド |
| US5223485A (en) * | 1989-01-31 | 1993-06-29 | Abbott Laboratories | Anaphylatoxin-receptor ligands |
| HU225068B1 (en) * | 1989-03-17 | 2006-05-29 | Chiron Corp | Process for producing diagnostics and vaccine of nanbh |
| AU8228791A (en) * | 1990-06-15 | 1992-01-07 | New York University | Heterohybridomas producing human monoclonal antibodies to hiv-1 |
| US5387671A (en) * | 1990-12-27 | 1995-02-07 | Abbott Laboratories | Hexa- and heptapeptide anaphylatoxin-receptor ligands |
| JP3908271B2 (ja) * | 1993-03-05 | 2007-04-25 | エピミューン，インコーポレイティド | Ｈｌａ−ａ２．１結合ペプチドおよびそれらの使用 |
| DE69534077T2 (de) * | 1994-01-14 | 2005-08-11 | Rath, Matthias, Dr.med. | Verwendung von methoden zur identifizierung von hydrophilen signal-oligopeptiden |
| US5709995A (en) * | 1994-03-17 | 1998-01-20 | The Scripps Research Institute | Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
| CA2186873A1 (en) * | 1994-04-01 | 1995-10-12 | Charles J. Hackett | Haptenated peptides and uses thereof |
| DE69617396T2 (de) * | 1995-01-16 | 2002-09-05 | Northern Sydney Area Health Service, St. Leonards | T-Zellen beeinflussende Peptide |
| US5753625A (en) * | 1995-05-12 | 1998-05-19 | Sangstat Medical Corporation | Treatment for inhibiting the progression of autoimmune disease |
-
1996
- 1996-01-16 DE DE69617396T patent/DE69617396T2/de not_active Expired - Lifetime
- 1996-01-16 US US08/875,013 patent/US6057294A/en not_active Expired - Fee Related
- 1996-01-16 CA CA002210812A patent/CA2210812C/en not_active Expired - Fee Related
- 1996-01-16 EP EP96900472A patent/EP0804469B1/en not_active Expired - Lifetime
- 1996-01-16 WO PCT/AU1996/000018 patent/WO1996022306A1/en not_active Ceased
- 1996-01-16 JP JP52191796A patent/JP3665342B2/ja not_active Expired - Fee Related
- 1996-01-16 ES ES96900472T patent/ES2168456T3/es not_active Expired - Lifetime
- 1996-01-16 AU AU44272/96A patent/AU694602B2/en not_active Ceased
-
2005
- 2005-02-10 JP JP2005034053A patent/JP2005145985A/ja active Pending
-
2006
- 2006-01-10 JP JP2006002633A patent/JP4522367B2/ja not_active Expired - Fee Related